Used in the development of targeted cancer therapies, particularly for multiple myeloma. It acts as a key intermediate in the synthesis of immunomodulatory drugs, enhancing their efficacy. The compound is designed to improve the binding affinity and selectivity of drugs to specific cellular targets, aiding in the inhibition of tumor growth. Its application is crucial in the research and production of next-generation treatments for hematologic malignancies.